Evidence map›Paper›PMID 31400292›Full record

ReviewFEBS letters2019

Ypt/Rab GTPases and their TRAPP GEFs at the Golgi.

Zhanna Lipatova, Nava Segev

Open access · greenAbstract readReview
In one paragraph

Review in FEBS letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Regulation of yeast polarized exocytosis by phosphoinositide lipids.Cellular and molecular life sciences : CMLS · 2024
    Review
  5. Article
  6. Expanding the phenotypic spectrum ofJournal of medical genetics · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zhanna LipatovaDepartment of Biochemistry and Molecular Genetics, University of Illinois at Chicago, IL, USA.
Nava SegevDepartment of Biochemistry and Molecular Genetics, University of Illinois at Chicago, IL, USA.ORCID 0000-0001-9319-0613
University of Illinois Chicago · US

Funding

YPTL GTPASE AND VESICULAR TRANSPORTR01GM045444 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SEGEV, NAVA · 1992 to 2020
$6.4M
Coordination of intracellular trafficking pathways by Ypt/Rab GTPases and their GEFs.R35GM141479 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SEGEV, NAVA · 2021 to 2025
$2.4M
The role of Rab1 GTPase and its activators in selective autophagy and neurodegenerative diseaseR21NS099556 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SEGEV, NAVA · 2016 to 2017
$400k
NIGMS NIH HHS R01 GM045444NIGMS NIH HHS R35 GM141479NINDS NIH HHS R21 NS099556
6 · The paper itself

Abstract

The conserved Ypt/Rab GTPases regulate the different steps of all intracellular trafficking pathways. Ypt/Rabs are activated by their specific nucleotide exchangers termed GEFs, and when GTP bound, they recruit their downstream effectors, which mediate vesicular transport substeps. In the yeast exocytic pathway, Ypt1 and Ypt31/32 regulate traffic through the Golgi and the conserved modular TRAPP complex acts a GEF for both Ypt1 and Ypt31/32. However, the precise localization and function of these Ypts have been under debate, as is the identity of their corresponding GEFs. We have established that Ypt1 and Ypt31 reside on the two sides of the Golgi, early and late, respectively, and regulate Golgi cisternal progression. We and others have shown that whereas a single TRAPP complex, TRAPP II, activates Ypt31, three TRAPP complexes can activate Ypt1: TRAPPs I, III, and IV. We propose that TRAPP I and II activate Ypt1 and Ypt31, respectively, at the Golgi, whereas TRAPP III and IV activate Ypt1 in autophagy. Resolving these issues is important because both Rabs and TRAPPs are implicated in multiple human diseases, ranging from cancer to neurodegenerative diseases.

Indexed as

AnimalsGolgi ApparatusGuanine Nucleotide Exchange FactorsHumansProtein Transportrab GTP-Binding ProteinsVesicular Transport ProteinsGuanine Nucleotide Exchange Factorsrab GTP-Binding ProteinsVesicular Transport Proteinscisternal maturationGolgiGolgi cisternal progressionTRAPP complexesYpt1Ypt31Ypt/Rab GTPases

Identifiers

PMID31400292
PMCPMC6989042
OpenAlexW2966948386

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.